Initial Pseudomonas aeruginosa infection in patients with cystic fibrosis: characteristics of eradicated and persistent isolates

被引:32
作者
Tramper-Stranders, G. A. [1 ]
van der Ent, C. K. [1 ]
Molin, S. [2 ]
Yang, L. [2 ]
Hansen, S. K. [2 ]
Rau, M. H. [2 ]
Ciofu, O. [3 ]
Johansen, H. K. [4 ,5 ]
Wolfs, T. F. W. [6 ]
机构
[1] Wilhelmina Childrens Hosp, Cyst Fibrosis Ctr, Univ Med Ctr Utrecht, Dept Paediat Resp Med, NL-3508 AB Utrecht, Netherlands
[2] Tech Univ Denmark, Infect Microbiol Grp, Ctr Syst Biol, DK-2800 Lyngby, Denmark
[3] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark
[4] Rigshosp, Dept Clin Microbiol, DK-2100 Copenhagen, Denmark
[5] Rigshosp, Danish CF Ctr, DK-2100 Copenhagen, Denmark
[6] Wilhelmina Childrens Hosp, Dept Paediat Infect Dis, Univ Med Ctr Utrecht, NL-3508 AB Utrecht, Netherlands
关键词
Chronic infection; cystic fibrosis; genotyping; Pseudomonas aeruginosa; virulence; III SECRETION; PULMONARY INFECTIONS; GENETIC ADAPTATION; DCTA GENE; COLONIZATION; VIRULENCE; STRAINS; MICROEVOLUTION; INACTIVATION; PATHOGEN;
D O I
10.1111/j.1469-0691.2011.03627.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Clin Microbiol Infect 2012; 18: 567574 Abstract Despite intensive eradication therapy, some CF patients with early Pseudomonas aeruginosa infection rapidly develop a chronic infection. To elucidate factors associated with this persistence, bacterial characteristics of early P. aeruginosa isolates were analysed that were either eradicated rapidly or persisted despite multiple antimicrobial treatments. Eighty-six early infection episodes were studied. First P. aeruginosa isolates from patients with eradication (36) or persistent infection (16) were included; isolates from patients with intermittent infection (34) were omitted from the study. Virulence assays, antimicrobial resistance, cytotoxicity and mutation frequencies were analysed in vitro. P. aeruginosa was genotyped by SNP-array. Transcriptomic profiles of two eradicated and two persistent strains were compared. Nineteen per cent of patients developed persistent infection; 42% achieved eradication. Secretion of virulence factors and mutation frequencies were highly variable among both eradicated and persistent isolates and were not different between the groups. Cytotoxicity was present in 57% of eradicated vs. 100% of persistent isolates (p <0.01). None of the isolates were resistant to antibiotics. The isolates were genotypically highly diverse. Multivariate analysis showed that in vitro determined bacterial characteristics could not predict persistence after first P. aeruginosa infection. Preliminary transcriptomic data showed increased expression of some genes related to a metabolic pathway. The early onset of chronic infection was not associated with (in vitro determined) bacterial characteristics only. Although the persistent isolates were more often cytotoxic, for the individual patient it was not possible to predict the risk of persistence based on bacterial characteristics. Unknown factors such as host-pathogen and pathogen-pathogen interactions should be further explored.
引用
收藏
页码:567 / 574
页数:8
相关论文
共 50 条
  • [31] The Approach to Pseudomonas aeruginosa in Cystic Fibrosis
    Bendiak, Glenda N.
    Ratjen, Felix
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 30 (05) : 587 - 595
  • [32] Chronic inhaled antibiotic therapy in people with cystic fibrosis with Pseudomonas aeruginosa infection in Germany
    Naehrig, S.
    Schulte-Hubbert, B.
    Hafkemeyer, S.
    Hammermann, J.
    Dumke, M.
    Sieber, S.
    Naehrlich, L.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 80
  • [33] Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Islam, S.
    Oh, H.
    Jalal, S.
    Karpati, F.
    Ciofu, O.
    Hoiby, N.
    Wretlind, B.
    CLINICAL MICROBIOLOGY AND INFECTION, 2009, 15 (01) : 60 - 66
  • [34] Epidemiology of Clonal Pseudomonas aeruginosa Infection in a Canadian Cystic Fibrosis Population
    Middleton, Maggie A.
    Layeghifard, Mehdi
    Klingel, Michelle
    Stanojevic, Sanja
    Yau, Yvonne C. W.
    Zlosnik, James E. A.
    Coriati, Adele
    Ratjen, Felix A.
    Tullis, Elizabeth D.
    Stephenson, Anne
    Wilcox, Pearce
    Freitag, Andreas
    Chilvers, Mark
    McKinney, Martha
    Lavoie, Annick
    Wang, Pauline W.
    Guttman, David S.
    Waters, Valerie J.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (07) : 827 - 836
  • [35] Multilocus amplicon sequencing of Pseudomonas aeruginosa cystic fibrosis airways isolates collected prior to and after early antipseudomonal chemotherapy
    Fischer, Sebastian
    Greipel, Leonie
    Klockgether, Jens
    Dorda, Marie
    Wiehlmann, Lutz
    Cramer, Nina
    Tuemmler, Burkhard
    JOURNAL OF CYSTIC FIBROSIS, 2017, 16 (03) : 346 - 352
  • [36] TYPING OF POLYAGGLUTINABLE PSEUDOMONAS-AERUGINOSA ISOLATES FROM CYSTIC-FIBROSIS PATIENTS
    OJENIYI, B
    WOLZ, C
    DORING, G
    LAM, JS
    ROSDAHL, VT
    HOIBY, N
    APMIS, 1990, 98 (05) : 423 - 431
  • [37] Impact of CFTR Modulation on Pseudomonas aeruginosa Infection in People With Cystic Fibrosis
    Ledger, Emma L.
    Smith, Daniel J.
    Teh, Jing Jie
    Wood, Michelle E.
    Whibley, Page E.
    Morrison, Mark
    Goldberg, Joanna B.
    Reid, David W.
    Wells, Timothy J.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (03) : e536 - e547
  • [38] Pseudomonas aeruginosa biofilms in cystic fibrosis
    Hoiby, Niels
    Ciofu, Oana
    Bjarnsholt, Thomas
    FUTURE MICROBIOLOGY, 2010, 5 (11) : 1663 - 1674
  • [39] Genetic relatedness and host specificity of Pseudomonas aeruginosa isolates from cystic fibrosis and non-cystic fibrosis patients
    AbdulWahab, Atqah
    Taj-Aldeen, Saad J.
    Ibrahim, Emad
    Abdulla, Shaikha H.
    Muhammed, Ramees
    Ahmed, Irshad
    Abdeen, Yasmine
    Sadek, Omnia
    Abu-Madi, Marawan
    INFECTION AND DRUG RESISTANCE, 2014, 7 : 309 - 316
  • [40] Pyoverdine-Dependent Virulence of Pseudomonas aeruginosa Isolates From Cystic Fibrosis Patients
    Kang, Donghoon
    Revtovich, Alexey, V
    Chen, Qingquan
    Shah, Kush N.
    Cannon, Carolyn L.
    Kirienko, Natalia, V
    FRONTIERS IN MICROBIOLOGY, 2019, 10